A$2.33
4.96% today
Australia, Nov 17, 06:10 am CET
ISIN
AU000000MSB8
Symbol
MSB

Mesoblast Target price 2025 - Analyst rating & recommendation

Mesoblast Classifications & Recommendation:

Buy
80%
Hold
20%

Mesoblast Price Target

Target Price A$3.17
Price A$2.33
Potential
Number of Estimates 4
4 Analysts have issued a price target Mesoblast 2026 . The average Mesoblast target price is A$3.17. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 8 Analysts recommend Mesoblast to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Mesoblast stock has an average upside potential 2026 of . Most analysts recommend the Mesoblast stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Jun '25 2026
Estimates
Revenue Million A$ 26.33 142.40
191.26% 440.83%
EBITDA Margin -478.58% -20.42%
56.81% 95.73%
Net Margin -593.96% -202.72%
60.13% 65.87%

6 Analysts have issued a sales forecast Mesoblast 2026 . The average Mesoblast sales estimate is

A$142m
Unlock
. This is
440.83% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
A$173m 557.64%
Unlock
, the lowest is
A$85.5m 224.84%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 A$26.3m 191.26%
2026
A$142m 440.83%
Unlock
2027
A$300m 110.74%
Unlock
2028
A$735m 144.80%
Unlock
2029
A$1.4b 91.50%
Unlock
2030
A$1.4b 2.53%
Unlock
2031
A$2.0b 45.49%
Unlock
2032
A$1.4b 27.41%
Unlock

7 Mesoblast Analysts have issued a net profit forecast 2026. The average Mesoblast net profit estimate is

A$-289m
Unlock
. This is
84.58% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
A$-20.6m 86.84%
Unlock
, the lowest is
A$-941m 501.75%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 A$-156m 16.13%
2026
A$-289m 84.58%
Unlock
2027
A$81.2m 128.13%
Unlock
2028
A$685m 743.81%
Unlock
2029
A$1.2b 72.47%
Unlock

Net Margin

2025 -593.96% 60.13%
2026
-202.72% 65.87%
Unlock
2027
27.06% 113.35%
Unlock
2028
93.28% 244.72%
Unlock
2029
84.01% 9.94%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Jun '25 2026
Estimates
Earnings Per Share A$ -0.13 -0.23
7.14% 76.92%
P/E negative
EV/Sales 20.45

7 Analysts have issued a Mesoblast forecast for earnings per share. The average Mesoblast EPS is

A$-0.23
Unlock
. This is
76.92% lower
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
A$-0.02 84.62%
Unlock
, the lowest is
A$-0.74 469.23%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 A$-0.13 7.14%
2026
A$-0.23 76.92%
Unlock
2027
A$0.06 126.09%
Unlock
2028
A$0.54 800.00%
Unlock
2029
A$0.92 70.37%
Unlock

P/E ratio

Current -17.08 71.38%
2026
-9.84 42.38%
Unlock
2027
34.99 455.59%
Unlock
2028
4.15 88.14%
Unlock
2029
2.40 42.17%
Unlock

Based on analysts' sales estimates for 2026, the Mesoblast stock is valued at an EV/Sales of

20.45
Unlock
and an P/S ratio of
20.80
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 110.58 39.78%
2026
20.45 81.51%
Unlock
2027
9.70 52.55%
Unlock
2028
3.96 59.15%
Unlock
2029
2.07 47.78%
Unlock
2030
2.12 2.59%
Unlock
2031
1.46 31.27%
Unlock
2032
2.01 37.76%
Unlock

P/S ratio

Current 112.50 35.37%
2026
20.80 81.51%
Unlock
2027
9.87 52.55%
Unlock
2028
4.03 59.15%
Unlock
2029
2.11 47.78%
Unlock
2030
2.16 2.59%
Unlock
2031
1.48 31.27%
Unlock
2032
2.05 37.77%
Unlock

Current Mesoblast Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
PIPER SANDLER COMPANIES
Locked
Locked
Locked Sep 10 2025
JEFFERIES
Locked
Locked
Locked Sep 08 2025
MAXIM GROUP
Locked
Locked
Locked Sep 04 2025
CANTOR FITZGERALD
Locked
Locked
Locked Sep 02 2025
BELL POTTER SECURITIES
Locked
Locked
Locked Sep 01 2025
CANACCORD GENUITY
Locked
Locked
Locked Sep 01 2025
JEFFERIES
Locked
Locked
Locked Jul 18 2025
Analyst Rating Date
Locked
PIPER SANDLER COMPANIES:
Locked
Locked
Sep 10 2025
Locked
JEFFERIES:
Locked
Locked
Sep 08 2025
Locked
MAXIM GROUP:
Locked
Locked
Sep 04 2025
Locked
CANTOR FITZGERALD:
Locked
Locked
Sep 02 2025
Locked
BELL POTTER SECURITIES:
Locked
Locked
Sep 01 2025
Locked
CANACCORD GENUITY:
Locked
Locked
Sep 01 2025
Locked
JEFFERIES:
Locked
Locked
Jul 18 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today